PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

UK government to cut cost of repeatable HRT prescriptions

The government has promised a cut to the cost of Hormone Replacement Therapy (HRT) prescriptions for women approaching or experiencing symptoms of menopause.

A new government Menopause Taskforce has also been announced, and this will be co-chaired by the Minister for Women’s Health, Maria Caulfield and Labour MP Carolyn Harris, the latter of whom was pushing for a law to make the treatment free of charge in England.

HRT treats menopause symptoms by replacing hormones that are at a lower level for those experiencing it. It works by replacing the hormone, oestrogen, which a woman’s body stops producing when they go through menopause.

Currently, a prescription for HRT costs £9.35 – or £18.70 if a woman needs two types of hormones. This is often only provided on a short-term basis, meaning that the cost has to be paid regularly, once a month or every three months.

According to the BBC – under the new government proposal, HRT prescriptions will be made available on an annual basis, meaning that someone only needs to pay the prescription charge once a year. This could reduce the cost by between £90 and £200.

On this development, Carolyn Harris MP commented: “Today is a result for women across the country. The bill was never about wins for either side of the political divide – it was about winning the 51% of the population who will directly experience menopause.

“The cost of HRT NHS prescriptions will be slashed – with the government committing to working towards getting this down to a single prescription charge per year – and the new task force will look at all the other areas of support which are currently falling short and failing women.”

The Civil Service is also currently developing its first workplace menopause policy to further support women going through menopause.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026